Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Psychiatrie
»
Schizophrenie und Psychosen
15. Februar 2026
Suchen
medline.ch
Schizophrenie und Psychosen
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Angst- und Panikstörungen
Demenz
Depression
Essstörungen
Persönlichkeits- störungen
Schizophrenie und Psychosen
Schlafstörungen
Sexuelle Störungen
Somatoforme Störungen
Sucht
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 3402
Artikel 1 - 20 / 68036
Strategies for enhancing methodological rigor and clinical relevance of eating disorders-schizophrenia spectrum disorders risk association studies.
Eur Neuropsychopharmacol
Ma JY, Tang F, Zhang Y, Hu J.
PMID: 41690187 [PubMed - as supplied by publisher]
The impact of CNV burden on age at onset of schizophrenia.
Schizophr Res
Muntané G, Valle A, Ramon-Cañellas P, Martorell L, Vilella E.
PMID: 41690160 [PubMed - as supplied by publisher]
A systematic review of the bidirectional relationship between psychosis and loneliness.
J Psychiatr Res
Ortiz-Tallo A, Izquierdo A, Calvo A, Lara E, Ayuso-Mateos JL, Cabello M.
PMID: 41690153 [PubMed - as supplied by publisher]
Comment on The nature and correlates of childhood trauma in individuals at clinical-high risk (CHR) for psychosis: A cross-country study in Brazil, China and Turkey.
Asian J Psychiatr
Qiao F, Sun M, Hua W.
PMID: 41690062 [PubMed - as supplied by publisher]
Letter to the Editor regarding "Social networks and symptomatology in recently hospitalized individuals with schizophrenia-spectrum disorders: A six-month longitudinal study".
Psychiatry Res
Zhang HM, Zhang YH.
PMID: 41689910 [PubMed - as supplied by publisher]
Influence of syringic acid on schizophrenia in mice: Modulation of PI3K/AKT1/GSK3β signaling pathway, galectin-3 and MBP.
Int Immunopharmacol
Salama A, Elwahab SA, El-Fadaly AA.
PMID: 41689874 [PubMed - as supplied by publisher]
Factors associated with hospitalisations over the two years following first episode psychosis in a remote setting: A retrospective cohort study.
Australas Psychiatry
Ritchie S, Mitchell D, Bressington D, Taft W, Mirza T.
PMID: 41689342 [PubMed - as supplied by publisher]
Reflections from individuals with schizophrenia on a life with delusions and hallucinations: a phenomenological study.
Ann Gen Psychiatry
Uzun S, Ediz Ç, Burak Erda.
PMID: 41689044 [PubMed - as supplied by publisher]
Excess mortality and life-years lost in older adults with schizophrenia-spectrum disorders: A 6-year follow-up case-control study.
Int Psychogeriatr
Fung CCS, Cheng CPW, Chan JKN, Chung TH, Lee ATC, Lam LCW, Sham PC, Wong MC, Chan LK, Tsoi ASH, Wong YC, Poon TK, Chan MC, Tse KTY, Liu HWS, Tang AYS, Cheung SH, Wong CSM, Chang WC, Chan WC.
PMID: 41688275 [PubMed - as supplied by publisher]
Effectiveness of a Combined High-Definition tDCS-Primed Intermittent Theta Burst Stimulation Protocol Targeting the Cerebellar Vermis in Treatment-Resistant Schizophrenia: a Randomized Sham-Controlled Trial.
Cerebellum
Ranjan A, Garg S, Dhyani M.
PMID: 41686308 [PubMed - indexed for MEDLINE]
Validation of a Traumatic Brain Injury Remediation Programme for Chronic Schizophrenia.
Ann Neurosci
Mishra SA, Mishra DK.
PMID: 41685269 [PubMed - as supplied by publisher]
Incidence and predictors of problem gambling in first-episode psychosis: a prospective multicentre cohort study.
Eur Psychiatry
Corbeil O, Huot-Lavoie M, Abdel-Baki A, Béchard L, Brodeur S, Artaud L, Constantinides P, Jacques C, Morin JF, Ouellet-Plamondon C, Solmi M, Talbot D, Dorval M, Giroux I, Roy MA, Demers MF.
PMID: 41684270 [PubMed - as supplied by publisher]
Pharmacological interventions for social cognitive impairments in schizophrenia: A systematic review and network meta-analysis of randomized controlled trials.
Eur Psychiatry
Yamada Y, Watanabe N, Tomo Y, Tachimori H, Horinouchi T, Uchino T, Kubota R, Okano H, Ishikawa S, Sawagashira R, Takanobu K, Hasegawa Y, Sasaki Y, Nishiuchi M, Sumiyoshi T, Hashimoto N, Ikezawa S, Nemoto T, Okubo R.
PMID: 41684115 [PubMed - as supplied by publisher]
MTHFR and MTRR Polymorphisms Predict Sex-Dependent Psychotic Symptom Improvements, Not Metabolic Changes.
Int J Mol Sci
Nadalin S, Majdand, Vranekovi, Peitl V, Vilibi, Sili, Karlovi.
PMID: 41683775 [PubMed - indexed for MEDLINE]
Prevalence and associated risk factors of psychotic experiences in the general population during the COVID-19 pandemic: a systematic review and meta-analysis.
Ann Gen Psychiatry
Fekih-Romdhane F, Azzi V, Harb F, Obeid S, Hallit S.
PMID: 41680907 [PubMed]
Brain texture alterations predict subtle visual perceptual dysfunctions in recent onset psychosis and clinical high-risk state.
Transl Psychiatry
Lencer R, Sprenger A, Meyhöfer I, Dannlowski U, Romer G, Kambeitz-Ilankovic L, Kambeitz J, Lichtenstein T, Rosen M, Ruhrmann S, Haas SS, Salokangas RKR, Pantelis C, Bonivento C, Schultze-Lutter F, Meisenzahl E, Brambilla P, Bertolino A, Upthegrove R, Davatzikos C, Koutsouleris N, Borgwardt S, Andreou C, Korda A, PRONIA Consortium.
PMID: 41680137 [PubMed - as supplied by publisher]
Mindfulness-based group therapy for auditory hallucination management in schizophrenia: A randomized controlled trial.
J Psychiatr Res
Yang S, Zhou W, Qin Y, Zheng T, Huang F, Li C, Dai J, Zhou L, Li L, Wu F, Tang Q.
PMID: 41679222 [PubMed - as supplied by publisher]
Latency to Long-Acting Injectable Antipsychotic Initiation and Psychiatric Hospitalization in First-Episode Schizophrenia.
J Clin Psychiatry
Joo SW, Lee J.
PMID: 41678397 [PubMed - indexed for MEDLINE]
Psychosis: The Utility of Ketamine as a Pharmacological Model of Psychotic-like Symptoms in Rodents: A Review of Dosage Regimens.
Biology (Basel)
Rice CA, Stackman RW Jr.
PMID: 41677693 [PubMed]
Uncovering novel therapeutics for schizophrenia: a multitarget approach using the CANDO platform.
bioRxiv
Hu Y, Elefteriou K, Falls Z, Samudrala R.
PMID: 41676525 [PubMed]
Artikel 1 - 20 / 68036
Seite 1 von 3402
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung